Testing effectiveness (Phase 2)Study completedNCT00453895What this trial is testingSunitinib in Refractory Adrenocortical CarcinomaWho this might be right forAdrenocortical Carcinoma University of Wuerzburg 39
Not applicableLooking for participantsNCT07072143What this trial is testingAn International Study on Pediatric Patients With Rare Tumors.Who this might be right forParaganglioma/ PhaeochromocytomaMelanoma and Other Malignant Neoplasms of SkinGastrointestinal Stromal Tumor (GIST)+11 more Azienda Ospedaliera di Padova 6,250
Not applicableUnknownNCT03083834What this trial is testingSalivary Free Cortisol Response to Cosyntropin Stimulation Test in Mitotane Treated PatientsWho this might be right forAdrenal InsufficiencyAdrenal Cancer Bnai Zion Medical Center 50
Early research (Phase 1)Study completedNCT00005842What this trial is testingTrastuzumab Plus R115777 in Treating Patients With Advanced or Metastatic CancerWho this might be right forCancer National Cancer Institute (NCI) 24
Testing effectiveness (Phase 2)Ended earlyNCT00003453What this trial is testingAntineoplaston Therapy in Treating Patients With Stage IV Adrenal Gland CancerWho this might be right forStage IV Adrenocortical Carcinoma Burzynski Research Institute 6
Not applicableLooking for participantsNCT05783908What this trial is testingImpact of Non-magnetic Screen Respiratory Self-guidance During MRI-guided Radiotherapy Sessions for Mobile LesionsWho this might be right forPatient With Radiotherapy (Linac MRI)Mobile Cancerous Lesion Centre Georges Francois Leclerc 100
Not applicableStudy completedNCT02592356What this trial is testingEffect of Cabozantinib S-Malate or Lenvatinib Mesylate on Weight and Body Composition in Patients With Metastatic Endocrine CancerWho this might be right forDifferentiated Thyroid Gland CarcinomaMalignant Adrenal Gland PheochromocytomaMalignant Paraganglioma+1 more M.D. Anderson Cancer Center 23
Not applicableLooking for participantsNCT00453674What this trial is testingGerman Adrenocortical Carcinoma RegistryWho this might be right forAdrenocortical Carcinoma University of Wuerzburg 1,000
Early research (Phase 1)Study completedNCT01898715What this trial is testingPhase 1 Study of ATR-101 in Subjects With Advanced Adrenocortical CarcinomaWho this might be right forAdrenocortical CarcinomaAdrenal CancerACC Millendo Therapeutics, Inc. 63
Not applicableActive Not RecruitingNCT00568139What this trial is testingEvaluation of Side Effects of MitotaneWho this might be right forAdrenocortical Carcinoma University of Wuerzburg 400
Testing effectiveness (Phase 2)Active Not RecruitingNCT04284774What this trial is testingTipifarnib for the Treatment of Advanced Solid Tumors, Lymphoma, or Histiocytic Disorders With HRAS Gene Alterations, a Pediatric MATCH Treatment TrialWho this might be right forMalignant Solid NeoplasmRecurrent Adrenal Gland PheochromocytomaRecurrent Ectomesenchymoma+38 more National Cancer Institute (NCI) 5
Early research (Phase 1)Looking for participantsNCT04119024What this trial is testingGene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid TumorsWho this might be right forMetastatic Malignant Solid NeoplasmMetastatic MelanomaPathologic Stage IIIC Cutaneous Melanoma AJCC v8+14 more Anusha Kalbasi 18
Testing effectiveness (Phase 2)Looking for participantsNCT06683846What this trial is testingIvonescimab in the Treatment of Multiple Advanced TumorsWho this might be right forPheochromocytoma/ParagangliomaRhabdomyosarcomaPaget Disease, Extramammary+16 more Fudan University 400
Testing effectiveness (Phase 2)Study completedNCT00091182What this trial is testingOxaliplatin in Treating Young Patients With Recurrent Solid Tumors That Have Not Responded to Previous TreatmentWho this might be right forChildhood Central Nervous System Germ Cell TumorChildhood Extragonadal Germ Cell TumorChildhood Hepatoblastoma+23 more National Cancer Institute (NCI) 180
Testing effectiveness (Phase 2)Study completedNCT03008369What this trial is testingLenvatinib in Treating Patients With Metastatic or Advanced Pheochromocytoma or Paraganglioma That Cannot Be Removed by SurgeryWho this might be right forMalignant Adrenal Gland PheochromocytomaMalignant ParagangliomaMetastatic Adrenal Gland Pheochromocytoma Mayo Clinic 3
Testing effectiveness (Phase 2)UnknownNCT03612232What this trial is testingCabozantinib in Advanced Adrenocortical CarcinomaWho this might be right forAdrenocortical Carcinoma Wuerzburg University Hospital 37
Testing effectiveness (Phase 2)Looking for participantsNCT05286814What this trial is testingPDS01ADC in Combination With Hepatic Artery Infusion Pump (HAIP) and Systemic Therapy for Subjects With Metastatic Colorectal Cancer, Intrahepatic Cholangiocarcinoma, or Metastatic Adrenocortical CarcinomaWho this might be right forMetastatic Colorectal Cancer (Mcrc)Intrahepatic Cholangiocarcinoma (Icc)Intrahepatic Bile Duct Cancer+10 more National Cancer Institute (NCI) 70
Testing effectiveness (Phase 2)Study completedNCT00215202What this trial is testingPhase II Trial of ZD1839 (Iressa) in Patients With Nonresectable Adrenocortical Carcinoma (ACC)Who this might be right forNonresectable Adrenocortical Carcinoma Dartmouth-Hitchcock Medical Center 16
Early research (Phase 1)Study completedNCT00020579What this trial is testingMS-275 in Treating Patients With Advanced Solid Tumors or LymphomaWho this might be right forCancer National Institutes of Health Clinical Center (CC) 75
Very early researchEnded earlyNCT01086696What this trial is testingA Pilot Study of F-18 Paclitaxel (FPAC) PET for Evaluating Drug Delivery of Solid Tumors in Breast, Lung, Renal, and Adrenal CancersWho this might be right forBreast CancerLung CancerRenal Cancer+1 more National Cancer Institute (NCI) 6